Sho Kinguchi

Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy

Shinya Taguchi, Kengo Azushima, Takahiro Yamaji et al. · Scientific Reports · 2021 · 81 citations · Full text

Medicine, Pathology, Pharmacology +9

Adipocyte‐Specific Enhancement of Angiotensin II Type 1 Receptor‐Associated Protein Ameliorates Diet‐Induced Visceral Obesity and Insulin Resistance

Kengo Azushima, Kohji Ohki, Hiromichi Wakui et al. · Journal of the American Heart Association · 2017 · 39 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +16

Angiotensin II Type 1 Receptor‐Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin

Kazushi Uneda, Hiromichi Wakui, Akinobu Maeda et al. · Journal of the American Heart Association · 2017 · 39 citations · Full text

Life Sciences, Pathobiology, Physiology +12

An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model

Ryu Kobayashi, Hiromichi Wakui, Kengo Azushima et al. · Kidney International · 2017 · 37 citations

Medicine, Nephrology, Pharmacology +17

Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)

Sho Kinguchi, Hiromichi Wakui, Yuzuru Ito et al. · Cardiovascular Diabetology · 2019 · 36 citations · Full text

Medicine, Endocrinology, Pharmacology +17